Moderate Asymmetric Hypertrophy: Interventricular Septal Thickness
Moderate asymmetric hypertrophy in HCM is generally considered when interventricular septal thickness measures approximately 15-20 mm, though specific "moderate" thresholds are not explicitly defined in major guidelines.
Understanding the Spectrum of Hypertrophy in HCM
The major guidelines establish clear diagnostic thresholds but do not formally categorize "mild," "moderate," or "severe" hypertrophy with specific cutoffs 1. However, based on the clinical context provided in these guidelines, we can infer a practical framework:
Diagnostic and Risk Stratification Thresholds
- Diagnostic threshold: ≥15 mm is the standard diagnostic criterion for HCM 1
- Borderline: 13-14 mm (particularly with family history or genetic confirmation) 1
- Highest risk: ≥30 mm is associated with the highest sudden death risk 1
Practical Classification Framework
Based on the linear relationship between wall thickness and outcomes described in the guidelines 1, a reasonable interpretation for clinical practice would be:
- Mild hypertrophy: 15-19 mm
- Moderate hypertrophy: 20-24 mm
- Severe hypertrophy: 25-29 mm
- Extreme hypertrophy: ≥30 mm
Important Clinical Caveats
The pattern matters as much as the measurement. Asymmetric septal hypertrophy specifically refers to disproportionate thickening of the interventricular septum compared to other LV segments 1. The 2011 ACC/AHA guidelines note that approximately one-third of HCM patients have largely segmental wall thickening involving only a small portion of the left ventricle 1.
Key Measurement Considerations
- Include the right ventricular muscle bundle (RVMB) when measuring septal thickness, as recent evidence suggests this improves diagnostic accuracy for HCM 2
- Measurements should be taken at end-diastole on echocardiography 1
- The ratio of septal to posterior wall thickness ≥1.4 supports asymmetric hypertrophy 3
Differential Diagnosis Pitfalls
The 2014 ESC guidelines emphasize that LV wall thickness ≥15 mm in Caucasians (≥20 mm in Black individuals) favors HCM over hypertensive heart disease 4. Hypertension rarely causes wall thickness >18 mm and typically produces symmetric rather than asymmetric hypertrophy 5.
In athletes, physiologic hypertrophy rarely exceeds 13 mm in white athletes (up to 16 mm in Black male athletes), is typically symmetric, and is associated with LV cavity enlargement 6, 7.
Clinical Implications
While the guidelines don't formally define "moderate" hypertrophy, the critical clinical distinction is whether wall thickness is ≥30 mm, as this confers the highest sudden death risk and influences ICD decision-making 1, 8. The 2024 AHA/ACC guidelines incorporate septal thickness into pediatric risk stratification models 8, 9.
For practical purposes, septal thickness in the 15-25 mm range represents the most common presentation of HCM, with progressive risk as thickness increases, but without discrete "moderate" versus "severe" treatment thresholds beyond the 30 mm marker for highest risk 1.